XML 17 R2.htm IDEA: XBRL DOCUMENT v3.23.1
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash $ 75,052 $ 60,974
Accounts and other receivables, net (note 2) 5,538 5,132
Inventories (note 2) 8,814 6,596
Prepaid expenses and other current assets 515 456
Total current assets 89,919 73,158
Property and equipment, net (notes 4 and 10) 10,224 10,618
Goodwill 13,354 14,098
Other intangible assets (note 2) $ 52,755 $ 56,314
Operating Lease, Right-of-Use Asset, Statement of Financial Position Other intangible assets (note 2) Other intangible assets (note 2)
Other intangible assets - accumulated amortization $ (42,378) $ (38,552)
Other intangible assets, net (note 2) 10,377 17,762
Total assets 123,874 115,636
Current liabilities    
Accounts payable 1,218 761
Accrued expenses (note 2) $ 4,742 2,984
Operating Lease, Liability, Current, Statement of Financial Position Accrued expenses (note 2)  
Total current liabilities $ 5,960 3,745
Long term lease liability 341 396
Long term income tax payable (REPAT tax) (note 7) 1,256 1,675
Deferred tax liability - intangible assets 1,514 2,105
Deferred income taxes (note 7) 549 577
Total liabilities 9,620 8,498
Commitments and contingencies (notes 6 and 12) 0 0
Stockholders' equity    
Common stock, $.01 par value; 50,000 shares authorized, issued 3,628 shares in 2022 and 3,655 shares in 2021 36 37
Accumulated other comprehensive loss (12,039) (9,054)
Additional paid-in capital 251 841
Retained earnings 126,006 115,314
Total stockholders' equity 114,254 107,138
Total liabilities and stockholders' equity $ 123,874 $ 115,636